Skip to main content

Abstract

Photodynamic therapy is a nonsurgical therapeutic option for the management of endobronchial tumors. It involves intravenous injection of a photosensitizing drug, followed by direct application of a nonthermal laser. The laser provides the wavelength of light to activate the drug in the tumor. Once activated, the drug causes cell death through oxygen free radical generation, small vessel thrombosis, and a tumor-specific cytotoxic immunity. The necrotic debris should be removed by bronchoscopy to avoid airway obstruction.

Photodynamic therapy is currently indicated in patients with microinvasive endobronchial non-small cell lung cancer (NSCLC) and comorbidities that render them ineligible for surgical resections, where it is used with a curative intent and in patients with completely or partially obstructing endobronchial NSCLC who require debulking of the airway tumor for palliation of symptoms. Photodynamic therapy is also useful in debulking endobronchial metastatic lesions from nonpulmonary malignancies.

The major adverse reaction following PDT is skin photosensitivity that can be avoided with meticulous pre- and postprocedure patient education. Other adverse reactions include transient local inflammatory response, airway stenosis at the site of treatment, and, rarely, massive hemoptysis. The utility of PDT in the management of lung cancers is only expected to expand as newer photosensitizing drugs are developed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  1. Dougherty TJ, Potter WR, Weishaupt KR. The structure of the active component of hematoporphyrin derivative. In: Doiron DR, Gomer CJ, editors. Porphyrin localization and treatment of tumors. New York: A.R. Liss. 1984; pp. 301–314.

    Google Scholar 

  2. Lipson RL, Blades EJ, Olsen AM. Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. J Thorac Cardiovasc Surg. 1961;42:623–9.

    PubMed  CAS  Google Scholar 

  3. Dougherty TJ, Kaufman JE, Goldfarb A, et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38:2628–35.

    PubMed  CAS  Google Scholar 

  4. Hayata Y, Kato H, Konaka C, et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest. 1982;81:269–71.

    Article  PubMed  CAS  Google Scholar 

  5. Lo Cicero J, Metzdorff M, Almgren C. Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer. Chest. 1990;98:97–100.

    Article  Google Scholar 

  6. Ackroyd R, Kelty C, Brown N, et al. The history of photodetection and photodynamic therapy. Photochem Photobiol. 2001;74(5):656–69.

    Article  PubMed  CAS  Google Scholar 

  7. Gomer CJ, Dougherty TJ. Determination of [3H]- and [14C] hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res. 1979;39:146–51.

    PubMed  CAS  Google Scholar 

  8. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889–905.

    Article  PubMed  CAS  Google Scholar 

  9. Pass HI. Photodynamic therapy in oncology: mechanism and clinical use. J Natl Cancer Inst. 1993;8:443–56.

    Article  Google Scholar 

  10. Wieshaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976;36:2326–9.

    Google Scholar 

  11. Kessel D, Luo Y. Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol. 1998;42:89–95.

    Article  CAS  Google Scholar 

  12. Fingar VH. Vascular effects of photodynamic therapy. J Clin Laser Med Surg. 1996;14:323–8.

    PubMed  CAS  Google Scholar 

  13. Korbelik M. Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg. 1996;14:329–34.

    PubMed  CAS  Google Scholar 

  14. Hayata H, Kato H, Konaka C, et al. Photoradiation therapy with haematoporphyrin derivative in early and stage I lung cancer. Chest. 1982;81:269–77.

    Article  PubMed  CAS  Google Scholar 

  15. Moghissi K, Dixon K. Update on the current indications, practice and results of photodynamic therapy (PDT) in early central lung cancer (ECLC). Photodiagnosis Photodyn Ther. 2008;5:10–8.

    Article  PubMed  CAS  Google Scholar 

  16. Kennedy TC, McWilliams A, Edell E, et al. Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed). Chest. 2007;132:221–33.

    Article  Google Scholar 

  17. Koike T, Terashima M, Takizawa T, et al. Surgical results for centrally located early stage lung cancer. Ann Thorac Surg. 2000;70:1176–9.

    Article  PubMed  CAS  Google Scholar 

  18. Terzi A, Pelosi G, Falezza G, et al. Early hilar lung cancer clinical aspect and long term survival – identification of sub group IA patients with more favorable prognosis. Lung Cancer. 2000;27:119–24.

    Article  PubMed  CAS  Google Scholar 

  19. Ernst A, Feller-Kopman D, Becker HD, et al. Central airway obstruction. Am J Respir Crit Care Med. 2004;169:1278–97.

    Article  PubMed  Google Scholar 

  20. Shah SK, Ost D. Photodynamic therapy: a case series demonstrating its role in patients receiving mechanical ventilation. Chest. 2000;118:1419–23.

    Article  PubMed  CAS  Google Scholar 

  21. Lam S, Grafton C, Coy P, et al. Combined photodynamic therapy (PDT) using photofrin and radiotherapy (XRT) versus radiotherapy alone in patients with inoperable obstructive non-small cell bronchogenic carcinoma. SPIE. 1991;1616:20–8.

    Article  Google Scholar 

  22. Moghissi K, Dixon K, Hudson E, et al. Endoscopic laser therapy in malignant tracheobronchial obstruction using sequential Nd:YAG laser and photodynamic therapy. Thorax. 1997;52:281–3.

    Article  PubMed  CAS  Google Scholar 

  23. Freitag L, Ernst A, Thomas M, et al. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax. 2004;59:790–3.

    Article  PubMed  CAS  Google Scholar 

  24. McCaughan JS. Survival after photodynamic therapy to non-pulmonary metastatic endobronchial tumors. Lasers Surg Med. 1999;24:194–201.

    Article  PubMed  Google Scholar 

  25. Litle VR, Christie NA, Fernando HC, et al. Photodynamic therapy for endobronchial metastases from nonbronchogenic primaries. Ann Thorac Surg. 2003;76:370–5.

    Article  PubMed  Google Scholar 

  26. Reddy C, Michaud G, Majid A, et al. Photodynamic therapy in the management of endobronchial metastatic lesions from renal cell carcinoma. J Bronchol Inter Pulmonol. 2009;16:245–9.

    Article  Google Scholar 

  27. PHOTOFRIN® (porfimer sodium) injection US Package Insert, August 2008.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chakravarthy Reddy M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Reddy, C. (2013). Photodynamic Therapy. In: Ernst, A., Herth, F. (eds) Principles and Practice of Interventional Pulmonology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4292-9_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4292-9_37

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4291-2

  • Online ISBN: 978-1-4614-4292-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics